Distinct T cell signatures are associated with Staphylococcus aureus skin infection in pediatric atopic dermatitis

Julianne Clowry1,2,3, Daniel J Dempsey3, Tracey J Claxton3

  • 1Department of Dermatology, National Children's Research Centre, Children's Health Ireland at Crumlin, Dublin, Ireland.

JCI Insight
|May 8, 2024
PubMed

Insights

Atopic dermatitis (AD) involves Staphylococcus aureus skin infections. Researchers identified immune signatures in children with AD, revealing specific T cell changes that could guide new vaccine development.

Area of Science:

  • Immunology
  • Dermatology
  • Microbiology

Background:

  • Atopic dermatitis (AD) is a prevalent inflammatory skin condition, often complicated by Staphylococcus aureus infections.
  • Microbial dysbiosis, particularly S. aureus, is linked to AD flares and pathogenesis, yet current treatments have limited efficacy.
  • Developing an anti-S. aureus vaccine for AD is a promising alternative, but understanding T cell immunity is crucial.

Purpose of the Study:

  • To identify systemic and cutaneous immunological signatures associated with S. aureus skin infection (ADS.aureus) in pediatric AD.
  • To explore the role of T cell responses in the context of S. aureus infection in atopic dermatitis.
  • To uncover potential correlates of T cell immunity for future vaccine strategies.

Main Methods:

  • Utilized a combined Bayesian multinomial analysis on a pediatric AD cohort with ADS.aureus.
  • Analyzed systemic and cutaneous immunological profiles, focusing on chemokine and T cell subset alterations.
  • Compared immune responses between patients with and without S. aureus skin infection.

Main Results:

  • Identified an immunological signature (ADS.aureus) characterized by elevated cutaneous chemokines IP10 and TARC.
  • Observed suppressed systemic CD4+ and CD8+ T cells (except Th2), including Th1, memory IL-10+, and skin-homing Th17 cells.
  • Detected systemic gamma-delta (γδ) T cell expansion in ADS.aureus.

Conclusions:

  • The identified immune signature provides insights into T cell dynamics during S. aureus infections in pediatric AD.
  • Augmenting protective T cell subsets represents a potential therapeutic avenue for managing S. aureus in AD.
  • This research lays the groundwork for developing targeted immunotherapies and vaccines against S. aureus in atopic dermatitis.